AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Vaxxinity, Inc.

$0 -$0.00 (-75.00%)
OTC · 14 Sep 2026 18:22 UTC
Previous Close
$0
Day Range
$0$0.02
Year Range
$0$0.2
Market Cap
12.68K
AVG Volume
10.66K
Trailing/Forward PE
-0.2/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Other OTCUS
Revenue (USD)
-20K020K40K60K21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Revenue (USD) by quarter
PeriodRevenue (USD)
23 Q40
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
22 Q20
22 Q10
21 Q4-1K
21 Q350K
Net Income (USD)
-60M-40M-20M021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q4-11.39M
23 Q3-13.14M
23 Q2-13.98M
23 Q1-18.42M
22 Q4-20.47M
22 Q3-19.25M
22 Q2-17.28M
22 Q1-18.26M
21 Q4-48.19M
21 Q3-30.39M
Operating Income (USD)
-60M-40M-20M021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q4-11.65M
23 Q3-13.45M
23 Q2-14.43M
23 Q1-18.81M
22 Q4-20.82M
22 Q3-19.77M
22 Q2-17.22M
22 Q1-18.16M
21 Q4-47.85M
21 Q3-30.27M
EBITDA (USD)
-60M-40M-20M021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q4-10.75M
23 Q3-12.3M
23 Q2-13.3M
23 Q1-17.64M
22 Q4-19.67M
22 Q3-18.78M
22 Q2-16.83M
22 Q1-17.82M
21 Q4-47.68M
21 Q3-29.91M
Cash Flows (USD)
-30M-20M-10M021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q4-12.26M
23 Q3-13.31M
23 Q2-12.25M
23 Q1-20.22M
22 Q4-14.77M
22 Q3-11.72M
22 Q2-11.08M
22 Q1-20.23M
21 Q4-15.23M
21 Q3-21.12M
EPS (USD)
-0.4-0.3-0.2-0.1-021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX EPS (USD) by quarter
PeriodEPS (USD)
23 Q4-0.09
23 Q3-0.1
23 Q2-0.11
23 Q1-0.15
22 Q4-0.16
22 Q3-0.15
22 Q2-0.14
22 Q1-0.15
21 Q4-0.38
21 Q3-0.24
Expenses (USD)
020M40M60MR&DSG&ACapex21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q411.61M
23 Q313.57M
23 Q214.52M
23 Q118.98M
22 Q421.12M
22 Q320.09M
22 Q217.76M
22 Q118.88M
21 Q449.12M
21 Q330.37M
Cash & Debt (USD)
050M100M150MCashLong Term DebtShort Term Debt21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q430.39M
23 Q342.52M
23 Q255.85M
23 Q167.58M
22 Q486.83M
22 Q399.11M
22 Q2109.07M
22 Q1124.77M
21 Q4144.88M
21 Q389.38M
Debt ratios
00.250.50.75121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Debt ratios by quarter
PeriodDebt ratios
23 Q40.28
23 Q30.46
23 Q20.61
23 Q10.73
22 Q40.99
22 Q30.88
22 Q20.88
22 Q10.94
21 Q40.99
21 Q30.79
Margins
-5000%0%5000%10000%15000%20000%20 Q220 Q321 Q121 Q321 Q4
VAXX Margins by quarter
PeriodMargins
21 Q417500%
21 Q382%
21 Q194.12%
20 Q3-52.14%
20 Q247.95%
Return on Capital
-100%-50%0%50%21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Return on Capital by quarter
PeriodReturn on Capital
23 Q4-84.96%
23 Q3-55.45%
23 Q2-39.92%
23 Q1-39.93%
22 Q4-32.93%
22 Q3-23.99%
22 Q2-17.75%
22 Q1-16.21%
21 Q4-37.47%
21 Q319.31%
Shares Outstanding
050M100M150M21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Shares Outstanding by quarter
PeriodShares Outstanding
23 Q4127.22M
23 Q3126.74M
23 Q2126.48M
23 Q1126.06M
22 Q4126.06M
22 Q3126.04M
22 Q2125.95M
22 Q1125.71M
21 Q4125.39M
21 Q3125.39M
Book Value Per Share (USD)
-2-101221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q40.11
23 Q30.19
23 Q20.28
23 Q10.37
22 Q40.49
22 Q30.64
22 Q20.77
22 Q10.9
21 Q41.03
21 Q3-1.25
Total Assets (USD)
050M100M150M200M21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q4
VAXX Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q444.31M
23 Q357.48M
23 Q271.37M
23 Q185.53M
22 Q4106.4M
22 Q3122.96M
22 Q2137M
22 Q1147.53M
21 Q4166.67M
21 Q3134.92M
Employee Count
0255075100202120222023
VAXX Employee Count by quarter
PeriodEmployee Count
202357
202287
202189
Free Cash Flow Yield
-60000000%-40000000%-20000000%0%med -228116.3%Jan 25May 25Sep 25Jan 26May 26Sep 26
VAXX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-456232.61%
Sep 26-4562.33%
Aug 26-456232.61%
Aug 26-456232.61%
Aug 26-1789.15%
Aug 26-456232.61%
Jul 26-456232.61%
Jul 26-456232.62%
Jul 26-456232.61%
Jul 26-456232.62%
Jul 26-2723.78%
Jun 26-3258.8%
Jun 26-3041.55%
Jun 26-456232.62%
Jun 26-228116.31%
May 26-456232.61%
May 26-456232.61%
May 26-456232.62%
May 26-456232.61%
May 26-45623260.86%
Apr 26-45623260.86%
Apr 26-456232.61%
Apr 26-456232.61%
Apr 26-45623260.86%
Mar 26-45623.26%
Mar 26-4562.33%
Mar 26-456232.61%
Mar 26-4562.33%
Feb 26-228116.3%
Feb 26-228116.3%
Feb 26-456232.62%
Feb 26-2644.83%
Jan 26-456232.61%
Jan 26-456232.61%
Jan 26-456232.61%
Jan 26-4562.33%
Jan 26-114058.15%
Dec 25-152077.54%
Dec 25-114058.15%
Dec 25-152077.54%
Dec 25-228116.3%
Nov 25-2281.16%
Nov 25-3041.55%
Nov 25-456232.61%
Nov 25-456232.61%
Oct 25-456232.61%
Oct 25-3041.55%
Oct 25-45623.26%
Oct 25-45623260.86%
Oct 25-4562.33%
Sep 25-4562.33%
Sep 25-456232.61%
Sep 25-45623.26%
Sep 25-1140.58%
Aug 25-1036.89%
Aug 25-1520.78%
Aug 25-1061.01%
Aug 25-1824.93%
Aug 25-456232.61%
Jul 25-4562.33%
Jul 25-456232.62%
Jul 25-456232.61%
Jul 25-1520.78%
Jun 25-456232.61%
Jun 25-456232.62%
Jun 25-456232.62%
Jun 25-4562.33%
May 25-4562.33%
May 25-4562.33%
May 25-3041.55%
May 25-228116.31%
May 25-1013.85%
Apr 25-228116.31%
Apr 25-4562.33%
Apr 25-228116.31%
Apr 25-1140.58%
Mar 25-9124.65%
Mar 25-9124.65%
Mar 25-456232.62%
Mar 25-456232.62%
Feb 25-456232.62%
Feb 25-9124.65%
Feb 25-456232.62%
Feb 25-9124.65%
Jan 25-228116.3%
Jan 25-114058.15%
Jan 25-91246.52%
Jan 25-912.47%
Jan 25-8773.7%
Dec 24-228116.3%
Dec 24-152077.54%
Dec 24-456232.61%
Dec 24-456232.61%
Nov 24-456232.61%
Nov 24-228116.3%
Nov 24-228116.3%
Nov 24-228116.3%
Nov 24-22811.63%
Oct 24-22811.63%
Oct 24-22811.63%
Price to Sales
-600000-400000-2000000200000med 5693.39Dec 21Mar 22May 22Aug 22Oct 22Jan 23Mar 23
VAXX Price to Sales by quarter
PeriodPrice to Sales
Mar 23-270979.26
Mar 23-262156.68
Mar 23-257115.2
Mar 23-303748.84
Feb 23-284843.31
Feb 23-287364.05
Feb 23-354163.59
Feb 23-504147.46
Jan 23-451211.98
Jan 23-378110.59
Jan 23-254594.47
Jan 23-219304.15
Dec 22-176451.61
Dec 22-194096.77
Dec 22-191576.03
Dec 22-234428.57
Dec 22-257115.2
Nov 22-219304.15
Nov 22-225605.99
Nov 22-191576.03
Nov 223547.12
Oct 223701.35
Oct 223906.98
Oct 224164.01
Oct 225063.65
Sep 225089.35
Sep 225423.5
Sep 225500.61
Sep 225552.02
Sep 226014.69
Aug 225911.87
Aug 225834.76
Aug 226117.5
Aug 225900.63
Jul 224489.61
Jul 224310.02
Jul 224361.33
Jul 224874.43
Jul 224489.61
Jun 224130.44
Jun 225336.22
Jun 226542
Jun 2211493.39
May 2211544.7
May 2211339.46
May 2211211.19
May 2210468.35
Apr 2213194.68
Apr 226079.62
Apr 226573.59
Apr 227884.51
Apr 228549.47
Mar 227618.53
Mar 227411.35
Mar 226980.9
Mar 228553
Feb 229395.2
Feb 229956.67
Feb 2211491.34
Feb 2211641.07
Jan 2211060.88
Jan 2215271.88
Jan 2212052.81
Jan 2210649.14
Dec 2110499.42
Dec 2112034.09
Dec 216358.69
Dec 217643.46
Dec 218211.37
Nov 2117186.15
Nov 2115054.17
Nov 2112568.42
Price to Book
00.20.40.6med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VAXX Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260.09
Aug 260
Aug 260
Aug 260.24
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260.16
Jun 260.13
Jun 260.14
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260.01
Mar 260.09
Mar 260
Mar 260.09
Feb 260
Feb 260
Feb 260
Feb 260.16
Jan 260
Jan 260
Jan 260
Jan 260.09
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250.19
Nov 250.14
Nov 250
Nov 250
Oct 250
Oct 250.14
Oct 250.01
Oct 250
Oct 250.09
Sep 250.09
Sep 250
Sep 250.01
Sep 250.38
Aug 250.42
Aug 250.28
Aug 250.41
Aug 250.24
Aug 250
Jul 250.09
Jul 250
Jul 250
Jul 250.28
Jun 250
Jun 250
Jun 250
Jun 250.09
May 250.09
May 250.09
May 250.14
May 250
May 250.43
Apr 250
Apr 250.09
Apr 250
Apr 250.38
Mar 250.05
Mar 250.05
Mar 250
Mar 250
Feb 250
Feb 250.05
Feb 250
Feb 250.05
Jan 250
Jan 250
Jan 250
Jan 250.47
Jan 250.05
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240.02
Oct 240.02
Oct 240.02
Vaxxinity, Inc.
VAXX
Stockpicker

Video analysis: VAXX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.